Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticancer drug   Durvalumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Imfinzi Canada, France, Germany, Great Britain, Switzerland, United States of America
Stability in solutions   injection   Stability in solutions : Durvalumab     
Container Solvent Concentration Temperature Storage Duration of stability References
partially used vials None 50 mg/ml 2-8°C Protect from light
28 Day
4767
Level of evidence D
partially used vials None 50 mg/ml 20-25°C Protect from light
28 Day
4767
Level of evidence D
partially used vials None 50 mg/ml 20-25°C Light
14 Day
4772
Level of evidence A+
partially used vials None 50 mg/ml 4°C Protect from light
14 Day
4772
Level of evidence A+
Not specified NaCl 0,9% or Glucose 5% 1 >> 15 mg/ml 2-8°C Not specified
30 Day
4608
Manufacturer's stability data
Not specified NaCl 0,9% or Glucose 5% 1 >> 15 mg/ml 25°C Not specified
24 Hour
4608
Manufacturer's stability data
  Mentions Légales